Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $97.1800 (-1.03%) ($92.5000 - $98.0000) on Thu. Sep. 24, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.26% (three month average) | RSI | 69 | Latest Price | $97.1800(-1.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND advances 3.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) XBI(58%) IWO(56%) ARKG(52%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.63% in a week (0% probabilities). VIXM(-18%) TLT(-15%) UUP(-6%) IGOV(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.63% (StdDev 3.26%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $98.38(-1.22%) | 10 Day Moving Average | $97.73(-0.56%) | 20 Day Moving Average | $95.05(2.24%) | To recent high | -4.7% | To recent low | 16.8% | Market Cap | $1.562b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |